Exabis Library
Welcome to the e-CCO Library!
P732: Endoscopic Balloon Dilation Of Symptomatic Intestinal Crohn’s disease Strictures: Long-Term Data On Efficacy And Safety In A Cohort Of Patients Followed-up For 10 Years
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P732: Impact of different types of physical activity in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P733 The influence of concomitant familial Mediterranean fewer on Crohn’s disease course: Data from an FMF endemic area
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P733: Comparative Analysis of Monotherapy and Combination Biological Therapy for Crohn’s disease and ulcerative colitis: Results from a Multi-Country Study in Europe
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P733: Novelties of COVID-19 vaccination beyond efficacy: Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P733: Past history of bariatric surgery associated with increased risk of new onset inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P733: Serum interleukin-6 level predicts future outcomes of infliximab for ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P734 Should we have a higher threshold for anti-TNF serum levels in Crohn’s disease patients with perianal disease?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P734: A single measurement of fecal calprotectin, particularly if combined with hemoglobin and C-reactive protein levels, predicts Crohn's disease prognosis - a prospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P734: Anti-TNFa exposure during pregnancy is not associated with increased infection risk in exposed children during the first year of life
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P734: Combining endoscopic and histological activity for predicting response to treatment
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P734: The sex ratio of inflammatory bowel disease varies according to age at onset: results from a worldwide survey
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P735 Comparative assessment of probiotics and standard therapies for mild to moderate ulcerative colitis: A systematic review and network meta-analysis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P735: Immunogenicity differences between anti-TNF drugs
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P735: Incidence of venous thromboembolic complications in controlled trials of inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P735: Indirect burden of patients with moderate inflammatory bowel disease in Uppsala County Council, Sweden: a retrospective study using real-world data
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P735: Real-life experience with the use of Tofacitinib in Colombian patients with moderate to severe Ulcerative Colitis: a descriptive study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P736 Utility of infliximab serum concentration in inflammatory bowel disease treatment in real world practice at Hospital Universitario de Canarias
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P736: Characteristics of polymeric formula and mode of delivery of exclusive enteral nutrition have no effect on disease outcome and weight gain in children with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P736: Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM